Form 4: Cambrian BioPharma Inc. Acquires Stock Options in Sensei Biotherapeutics, Inc.
SEC Form 4 Filing
Cambrian BioPharma Inc., a 10% owner of Sensei Biotherapeutics, Inc., reports acquiring stock options exercisable for 19,000 shares of common stock.
Summary
- Cambrian BioPharma Inc., identified as a 10% owner of Sensei Biotherapeutics, Inc. (SNSE), filed a Form 4 with the SEC.
- The filing reports a transaction on June 11, 2024, where Cambrian BioPharma Inc. acquired stock options to purchase 19,000 shares of Sensei Biotherapeutics common stock at an exercise price of $0.709 per share.
- The options vest in 12 equal monthly installments, becoming fully vested by June 11, 2025, contingent upon continuous service with the issuer.
- The options will be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.
- Following the transaction, Cambrian BioPharma Inc. directly owns 19,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition. The acquisition itself could be seen as mildly positive, indicating confidence, but the document is primarily factual.
Positives
- Cambrian BioPharma Inc.'s acquisition of stock options may indicate confidence in Sensei Biotherapeutics' future performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedule implies a continued relationship between Cambrian BioPharma and Sensei Biotherapeutics.
Industry Context
Form 4 filings are standard disclosures for significant shareholders and insiders, providing transparency into their transactions and holdings in publicly traded companies. This filing indicates Cambrian BioPharma's ongoing investment in Sensei Biotherapeutics.
Stakeholder Impact
- Shareholders of Sensei Biotherapeutics may view this as a positive signal, indicating continued investment from a significant shareholder.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of the stock option transaction. |
| 06/11/2025 | Date by which the stock options are fully vested, subject to continuous service. |
| TBD | Date of the Company's next annual stockholder meeting, at which time the options will be fully vested, subject to the Reporting Person's continuous service with the Issuer through such vesting date. |
| 06/13/2024 | Date of the Form 4 filing. |
Keywords
Form 4, Sensei Biotherapeutics, Cambrian BioPharma, stock options, beneficial ownership, SNSE
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.